RecruitingNCT02026388
Rare Kidney Stone Consortium Biobank
Studying Adenine phosphoribosyltransferase deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mayo Clinic
- Principal Investigator
- John C Lieske, M.D., M.DMayo Clinic
- Enrollment
- 2000 enrolled
- Eligibility
- All sexes
- Timeline
- 2013 – 2030
Study locations (1)
- Mayo Clinic, Rochester, Minnesota, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02026388 on ClinicalTrials.govOther trials for Adenine phosphoribosyltransferase deficiency
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06065852National Registry of Rare Kidney DiseasesUK Kidney Association
- RECRUITINGNCT00588562Rare Kidney Stone Consortium Patient RegistryMayo Clinic
See all trials for Adenine phosphoribosyltransferase deficiency →